Annual CFO:
-$83.03M+$34.47M(+29.33%)Summary
- As of today, TARS annual cash from operations is -$83.03 million, with the most recent change of +$34.47 million (+29.33%) on December 31, 2024.
- During the last 3 years, TARS annual cash from operations has fallen by -$86.78 million (-2315.23%).
- TARS annual cash from operations is now -2315.23% below its all-time high of $3.75 million, reached on December 31, 2021.
Performance
TARS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$29.39M-$8.74M(-42.30%)Summary
- As of today, TARS quarterly cash from operations is -$29.39 million, with the most recent change of -$8.74 million (-42.30%) on June 30, 2025.
- Over the past year, TARS quarterly cash from operations has dropped by -$14.98 million (-104.02%).
- TARS quarterly cash from operations is now -243.00% below its all-time high of $20.55 million, reached on June 30, 2021.
Performance
TARS Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$80.87M-$14.98M(-22.74%)Summary
- As of today, TARS TTM cash from operations is -$80.87 million, with the most recent change of -$14.98 million (-22.74%) on June 30, 2025.
- Over the past year, TARS TTM cash from operations has increased by +$43.02 million (+34.72%).
- TARS TTM cash from operations is now -1481.01% below its all-time high of $5.86 million, reached on September 30, 2021.
Performance
TARS TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TARS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +29.3% | -104.0% | +34.7% |
| 3Y3 Years | -2315.2% | -590.0% | -229.4% |
| 5Y5 Years | -2160.5% | - | - |
TARS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -2315.2% | +29.3% | -239.7% | +25.3% | -64.9% | +39.3% |
| 5Y | 5-Year | -2315.2% | +29.3% | -243.0% | +25.3% | -1481.0% | +39.3% |
| All-Time | All-Time | -2315.2% | +29.3% | -243.0% | +25.3% | -1481.0% | +39.3% |
TARS Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$29.39M(-42.3%) | -$80.87M(-22.7%) |
| Mar 2025 | - | -$20.65M(+6.9%) | -$65.89M(+20.6%) |
| Dec 2024 | -$83.03M(+29.3%) | -$22.18M(-156.4%) | -$83.03M(+17.1%) |
| Sep 2024 | - | -$8.65M(+39.9%) | -$100.18M(+19.1%) |
| Jun 2024 | - | -$14.40M(+61.9%) | -$123.89M(+7.1%) |
| Mar 2024 | - | -$37.79M(+3.9%) | -$133.31M(-13.5%) |
| Dec 2023 | -$117.49M(-139.6%) | -$39.34M(-21.5%) | -$117.49M(-32.0%) |
| Sep 2023 | - | -$32.36M(-35.8%) | -$89.03M(-18.3%) |
| Jun 2023 | - | -$23.83M(-8.4%) | -$75.28M(-35.1%) |
| Mar 2023 | - | -$21.97M(-102.0%) | -$55.71M(-13.6%) |
| Dec 2022 | -$49.03M | -$10.87M(+41.6%) | -$49.03M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.61M(-337.0%) | -$50.28M(-104.8%) |
| Jun 2022 | - | -$4.26M(+72.1%) | -$24.55M(-9691.4%) |
| Mar 2022 | - | -$15.29M(-26.1%) | $256.00K(-93.2%) |
| Dec 2021 | $3.75M(+117.7%) | -$12.12M(-270.4%) | $3.75M(-36.0%) |
| Sep 2021 | - | $7.11M(-65.4%) | $5.86M(+566.2%) |
| Jun 2021 | - | $20.55M(+274.2%) | -$1.26M(+94.2%) |
| Mar 2021 | - | -$11.79M(-17.8%) | -$21.81M(-81.6%) |
| Dec 2020 | -$21.14M(-475.5%) | -$10.01M(-401.7%) | -$12.01M(-501.7%) |
| Mar 2020 | - | -$2.00M | -$2.00M |
| Dec 2019 | -$3.67M(-210.5%) | - | - |
| Dec 2018 | -$1.18M | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of TARS is -$83.03M
What is the all-time high annual cash from operations for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual cash from operations is $3.75M
What is Tarsus Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, TARS annual cash from operations has changed by +$34.47M (+29.33%)
What is Tarsus Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of TARS is -$29.39M
What is the all-time high quarterly cash from operations for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly cash from operations is $20.55M
What is Tarsus Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, TARS quarterly cash from operations has changed by -$14.98M (-104.02%)
What is Tarsus Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of TARS is -$80.87M
What is the all-time high TTM cash from operations for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM cash from operations is $5.86M
What is Tarsus Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, TARS TTM cash from operations has changed by +$43.02M (+34.72%)